Clin2
NCT07163650Possibly a fitRecruiting

Obesity medication 6 months after weight-loss surgery

ObesityWeight LossMetabolic Surgery

Treatments studied

Part of Hormones & metabolism clinical trials.

This trial is for people who had metabolic surgery 6 months ago and still have a BMI of 28 or higher. It tests whether an anti-obesity medication can help with further weight loss after surgery.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
60 people
Ages
18 years to 55 years
Study type
Interventional

Who can take part

  • You are between 18 and 55 years old.
  • You had metabolic (weight-loss) surgery at least 6 months ago.
  • Your BMI is 28 or higher.
  • You have not used any weight-loss drugs or supplements in the last 3 months.
  • You do not have a history of depression, severe mental illness, or certain heart conditions.
  • You are not pregnant or planning to become pregnant during the study.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06633783Not yet recruiting· Phase 3
Semaglutide injection for weight loss study

This study tests an injectable medication called semaglutide to help with weight loss in people with a BMI of 28 or higher who have struggled to lose weight before. It compares the study drug to a similar approved weight loss medicine (Wegovy).

Xuancheng, Anhui
NCT06423599Recruiting· Phase 2/Phase 3
Weight Loss for Obesity and Heart Failure

This study tests whether weight loss from a medication can improve how you feel, move, and how well your heart works. It's for people who have both obesity and heart failure with reduced pumping strength.

Copenhagen
NCT06825793Not yet recruiting
Semaglutide for weight loss in obesity

This study tests a medication called semaglutide (which helps with weight loss) in people with obesity who have struggled to lose weight before. It will see how much weight participants can lose while taking the drug.

NCT07633639Recruiting
GLP-1 Medicine After Weight-Loss Surgery in Chinese Patients

This trial tests whether adding a GLP-1 medication (a type of diabetes and weight-loss drug) after weight-loss surgery helps patients with obesity and related health conditions like diabetes. Researchers want to see if combining surgery with this medicine works better than surgery alone.

Beijing
NCT07336862Recruiting· Phase 1/Phase 2
Weight loss surgery plus GLP-1 drug for obesity and diabetes

This trial tests whether adding a GLP-1 receptor agonist (a medication that helps control blood sugar and appetite) after weight loss surgery improves outcomes for people with severe obesity and related health problems like type 2 diabetes.

Beijing
NCT07770841Recruiting· Phase 3
Oral medication for weight loss study

This study tests an oral medicine (semaglutide) to see if it helps adults with excess weight lose weight. It might offer an easier, pill-based treatment option for weight management.

Birmingham, Alabama

Hear when a new Obesity trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.